
  
    
      
        Background_NNP
        The_DT use_NN of_IN hair_NN assays_NNS in_IN order_NN to_TO assess_VB the_DT presence_NN
        of_IN ingested_JJ chemical_NN materials_NNS has_VBZ been_VBN used_VBN in_IN a_DT wide_JJ
        variety_NN of_IN applications_NNS [_NN 1_CD ,_, 2_CD ]_NN ._. Hair_NNP has_VBZ been_VBN utilized_JJ ,_,
        for_IN example_NN ,_, in_IN determining_VBG the_DT degree_NN of_IN exposure_NN to_TO heavy_JJ
        metals_NNS in_IN both_DT 
        post_NN mortem_NN and_CC living_VBG subjects_NNS [_NN 3_CD ]_NN ._.
        In_IN recent_JJ years_NNS there_RB has_VBZ been_VBN considerable_JJ focus_NN on_IN the_DT
        recovery_NN of_IN illicit_JJ psychoactive_JJ substances_NNS and_CC their_PRP$
        metabolites_NNS from_IN hair_NN [_NN 4_CD ,_, 5_CD ,_, 6_CD ]_NN ._. Others_NNS have_VBP reported_VBN on_IN a_DT
        wide_JJ variety_NN of_IN substances_NNS that_WDT can_MD be_VB recovered_VBN from_IN human_JJ
        hair_NN samples_NNS and_CC can_MD be_VB quantitatively_RB determined_VBN ._. These_DT
        include_VBP nicotine_NN and_CC cotinine_NN [_NN 7_CD ]_NN ,_, caffeine_NN [_NN 8_CD ]_NN ,_,
        antipsychotics_NNS and_CC anti-anxiety_JJ medications_NNS [_NN 9_CD ,_, 10_CD ,_, 11_CD ,_,
        12_CD ]_NN ,_, various_JJ antibiotics_NNS [_NN 13_CD ,_, 14_CD ,_, 15_CD ,_, 16_CD ]_NN ,_, pesticides_NNS [_NN
        17_CD ]_NN ,_, digoxin_NN [_NN 18_CD ]_NN ,_, and_CC steroids_NNS [_NN 19_CD ,_, 20_CD ]_NN ._. There_EX are_VBP
        several_JJ advantages_NNS to_TO hair_NN as_IN a_DT sample_NN for_IN analysis_NN ,_, but_CC
        the_DT single_JJ most_RBS important_JJ attribute_VBP is_VBZ undoubtedly_RB the_DT long_JJ
        retrospective_NN time_NN frame_NN to_TO which_WDT analysis_NN of_IN a_DT segment_NN of_IN
        hair_NN corresponds_NNS ._. This_DT permits_VBZ an_DT evaluation_NN of_IN a_DT history_NN
        of_IN exposure_NN that_WDT is_VBZ not_RB possible_JJ with_IN specimens_NNS such_JJ as_IN
        saliva_NN or_CC urine_NN ._. A_DT three-centimeter_JJ length_NN of_IN hair_NN
        corresponds_NNS ,_, on_IN average_JJ ,_, to_TO approximately_RB 90_CD days_NNS of_IN past_JJ
        time_NN or_CC "_'' history_NN "_'' ._. For_IN compounds_NNS that_WDT are_VBP stable_JJ when_WRB
        sequestered_VBN in_IN hair_NN this_DT represents_VBZ a_DT very_RB desirable_JJ
        property_NN ._.
        This_DT enhanced_VBN temporal_JJ capacity_NN lends_VBZ itself_PRP to_TO the_DT
        possibility_NN that_DT hair_NN analysis_NN can_MD be_VB utilized_JJ to_TO evaluate_VB
        individual_JJ compliance_NN for_IN substances_NNS that_WDT are_VBP taken_VBN on_IN a_DT
        regular_JJ basis_NN ,_, such_JJ as_IN anti-clotting_JJ medications_NNS ,_,
        antibiotics_NNS ,_, and_CC anti-epileptic_JJ drugs_NNS ._. This_DT can_MD be_VB an_DT
        important_JJ diagnostic_JJ and_CC assessment_NN aid_NN in_IN medical_JJ practice_NN
        and_CC clinical_JJ evaluation_NN of_IN drug_NN efficacy_NN ._. Williams_NNP ,_, for_IN
        example_NN ,_, has_VBZ advocated_VBN the_DT use_NN of_IN hair_NN analysis_NN as_IN a_DT method_NN
        for_IN assessing_VBG therapeutic_JJ compliance_NN to_TO anti-seizure_JJ drug_NN
        regimens_NNS [_NN 21_CD ]_NN ._. It_PRP has_VBZ been_VBN well_RB demonstrated_VBN that_IN the_DT
        major_JJ antiepileptic_JJ medications_NNS ,_, phenytoin_NN (_( PHT_NNP )_) ,_,
        carbamazepine_NN (_( CBZ_NNP )_) ,_, and_CC valproic_JJ acid_NN (_( VPA_NNP )_) are_VBP readily_RB
        recovered_VBN and_CC quantified_VBN from_IN hair_NN specimens_NNS [_NN [_NN 22_CD 23_CD 24_CD
        25_CD 26_CD 27_CD 28_CD 29_CD ]_NN ]_NN ._. Thus_RB ,_, assessing_VBG the_DT presence_NN and_CC
        quantity_NN of_IN these_DT substances_NNS in_IN hair_NN may_MD be_VB a_DT reliable_JJ
        marker_NN for_IN consumption_NN ,_, and_CC provide_VB an_DT additional_JJ source_NN of_IN
        information_NN to_TO the_DT physician_NN who_WP has_VBZ historically_RB relied_VBN
        only_RB on_IN the_DT patient_NN 's_POS self-reported_JJ compliance_NN ._.
        Whether_IN hair_NN analysis_NN can_MD be_VB an_DT effective_JJ indication_NN of_IN
        patient_NN compliance_NN is_VBZ controversial_JJ ,_, however_RB ._. It_PRP is_VBZ widely_RB
        accepted_VBN that_IN the_DT qualitative_JJ presence_NN of_IN these_DT compounds_NNS
        can_MD be_VB reliably_RB demonstrated_VBN by_IN hair_NN analysis_NN ._. The_DT
        controversial_JJ aspect_NN is_VBZ primarily_RB based_VBN on_IN the_DT issue_NN of_IN
        whether_IN the_DT 
        quantitative_JJ value_NN of_IN the_DT assay_NN can_MD
        be_VB a_DT reliable_JJ indicator_NN of_IN dose_NN ._. That_DT is_VBZ ,_, is_VBZ there_EX a_DT
        reliable_JJ dose_NN /_NN assay_NN correlation_NN ?_. Tracqui_NNP et_CC al_NN ._. [_NN 30_CD ]_NN ,_, for_IN
        example_NN ,_, have_VBP argued_VBN that_DT hair_NN analysis_NN has_VBZ value_NN for_IN
        qualitative_JJ evaluation_NN of_IN drug_NN use_NN ,_, but_CC is_VBZ "_'' worthless_JJ "_'' for_IN
        quantitative_JJ assessment_NN of_IN patient_NN compliance_NN ._. Williams_NNP
        (_( 1999_CD )_) ,_, however_RB ,_, argues_VBZ the_DT opposite_NN ,_, and_CC presents_VBZ data_NNS for_IN
        a_DT controlled_VBN inpatient_NN population_NN taking_VBG CBZ_NNP which_WDT shows_VBZ
        remarkably_RB good_JJ consistency_NN between_IN dose_NN and_CC assay_NN outcome_NN ._.
        Furthermore_RB ,_, Williams_NNP suggests_VBZ that_DT compliance_NN is_VBZ best_RBS
        measured_VBN by_IN using_VBG patients_NNS as_IN their_PRP$ own_JJ control_NN ._. This_DT is_VBZ
        done_VBN by_IN comparing_VBG any_DT given_VBN assay_NN outcome_NN to_TO a_DT ground_NN state_NN
        value_NN ._. So_RB hair_NN will_MD show_VB a_DT relative_JJ change_NN in_IN
        concentration_NN ._. It_PRP is_VBZ generally_RB accepted_VBN that_IN specific_JJ
        quantitative_JJ values_NNS related_VBN to_TO a_DT specific_JJ dose_NN can_MD not_RB
        applied_VBN across_IN study_NN subjects_NNS due_JJ to_TO substantive_JJ individual_JJ
        biovariability_NN ._.
        One_CD issue_NN that_WDT is_VBZ not_RB clearly_RB understood_VBN is_VBZ the_DT variety_NN
        of_IN factors_NNS influencing_VBG the_DT considerable_JJ biovariability_NN that_WDT
        appears_VBZ between_IN persons_NNS given_VBN identical_JJ dosages_NNS of_IN these_DT
        drugs_NNS ._. Clinicians_NNP general_JJ recognize_VB that_IN a_DT very_RB large_JJ
        number_NN of_IN factors_NNS can_MD influence_VB the_DT drug_NN concentration_NN in_IN
        any_DT analytic_JJ matrix_NN ._. One_CD potential_JJ advantage_NN of_IN hair_NN
        specimens_NNS is_VBZ they_PRP may_MD represent_VB a_DT relatively_RB stable_JJ matrix_NN
        over_IN a_DT relatively_RB long_JJ time_NN frame_NN ._. Tracqui_NNP ,_, even_RB in_IN
        rejecting_VBG the_DT utility_NN of_IN quantitative_JJ compliance_NN monitoring_VBG
        in_IN this_DT context_NN ,_, notes_NNS that_IN a_DT number_NN of_IN studies_NNS reported_VBD
        significant_JJ strong_JJ correlation_NN between_IN dose_NN and_CC assay_NN
        outcomes_NNS for_IN a_DT number_NN of_IN different_JJ compounds_NNS ,_, with_IN
        Pearson_NNP 's_POS r_LS ranging_VBG from_IN ._. 772_CD to_TO ._. 868_CD ._. Another_DT aspect_NN of_IN
        this_DT interpretation_NN controversy_NN concerns_NNS whether_IN there_EX are_VBP
        systematic_JJ influences_NNS on_IN drug_NN concentration_NN in_IN hair_NN because_IN
        of_IN color_NN variations_NNS ,_, differences_NNS in_IN cosmetic_JJ treatment_NN ,_, and_CC
        different_JJ intensities_NNS of_IN hair_NN hygiene_NN ._. Another_DT part_NN of_IN the_DT
        controversy_NN is_VBZ problems_NNS related_VBN to_TO the_DT dependency_NN on_IN the_DT
        accuracy_NN self-reported_JJ patient_NN compliance_NN (_( which_WDT may_MD or_CC may_MD
        not_RB be_VB accurate_JJ )_) ,_, and_CC -_: in_IN the_DT case_NN of_IN illicit_JJ drugs_NNS -_: the_DT
        purity_NN and_CC actual_JJ contents_NNS of_IN drugs_NNS reported_VBD as_IN consumed_VBN ._.
        The_DT attending_VBG physicians_NNS for_IN these_DT patients_NNS were_VBD queried_VBN on_IN
        the_DT confidence_NN they_PRP had_VBD on_IN their_PRP$ patient_NN 's_POS compliance_NN ,_, and_CC
        in_IN general_JJ they_PRP rated_VBD the_DT compliance_NN as_IN good_JJ ,_, with_IN only_RB a_DT
        small_JJ number_NN of_IN missed_VBD doses_NNS ._. However_RB ,_, we_PRP recognize_VBP that_IN
        there_EX are_VBP reliable_JJ data_NNS to_TO indicate_VB that_DT patient_NN compliance_NN
        to_TO anti-seizure_JJ medication_NN regimens_NNS may_MD be_VB weak_JJ ,_, and_CC a_DT
        delimitation_NN of_IN this_DT research_NN is_VBZ that_IN there_EX was_VBD not_RB rigid_JJ
        control_NN of_IN patient_NN compliance_NN ._.
        One_CD of_IN the_DT general_JJ weaknesses_NNS characterizing_VBG much_JJ of_IN the_DT
        analysis_NN of_IN hair_NN assay_NN data_NNS has_VBZ been_VBN the_DT inadequacy_NN of_IN the_DT
        statistical_JJ models_NNS used_VBN to_TO assess_VB the_DT experimental_JJ
        information_NN ._. Oftentimes_NNP claims_VBZ or_CC conclusions_NNS are_VBP derived_VBN
        from_IN experimental_JJ data_NNS that_WDT is_VBZ not_RB supported_VBN by_IN statistical_JJ
        analysis_NN ._. In_IN some_DT cases_NNS ,_, in_IN fact_NN ,_, analyses_NNS of_IN the_DT data_NNS show_VBP
        that_IN the_DT conclusions_NNS reached_VBN are_VBP clearly_RB incorrect_JJ [_NN 31_CD ]_NN ._.
        There_EX has_VBZ been_VBN ,_, in_IN general_JJ ,_, a_DT failure_NN in_IN the_DT assessment_NN of_IN
        experimental_JJ hair_NN analysis_NN data_NNS to_TO use_VB appropriate_JJ
        available_JJ statistical_JJ procedures_NNS ,_, or_CC to_TO assess_VB whether_IN the_DT
        critical_JJ assumptions_NNS that_WDT underlay_NN statistical_JJ procedures_NNS
        are_VBP met_VBN by_IN the_DT data_NNS ._. And_CC almost_RB without_IN exception_NN ,_, there_EX
        has_VBZ been_VBN no_DT utilization_NN of_IN more_JJR sophisticated_JJ and_CC sensitive_JJ
        statistical_JJ techniques_NNS that_WDT are_VBP available_JJ to_TO examine_VB
        multivariate_NN phenomena_NNS ._. This_DT is_VBZ true_JJ even_RB though_IN there_EX is_VBZ a_DT
        general_JJ recognition_NN that_IN the_DT relationship_NN between_IN dose_NN and_CC
        assay_NN are_VBP likely_JJ to_TO mediated_JJ by_IN a_DT complex_JJ series_NN of_IN
        intervening_VBG events_NNS and_CC are_VBP particularly_RB appropriate_JJ to_TO this_DT
        analytic_JJ approach_NN ._.
      
      
        Materials_NNS and_CC Methods_NNP
        The_DT analysis_NN is_VBZ based_VBN upon_IN the_DT concentrations_NNS obtained_VBN
        from_IN scalp_NN hair_NN collected_VBN by_IN cutting_VBG hair_NN from_IN the_DT
        posterior_NN vertex_NN of_IN the_DT head_NN ._. Each_DT sample_NN consisted_VBD of_IN
        approximately_RB 200_CD mg_NN of_IN hair_NN ._. Each_DT sample_NN was_VBD sectioned_JJ
        into_IN 2_CD -_: cm_NN segments_NNS and_CC each_DT segment_NN was_VBD analyzed_VBN by_IN FPIA_NNP
        and_CC HPLC_NNP methods_NNS for_IN CBZ_NNP and_CC PHT_NNP and_CC by_IN FPIA_NNP for_IN VPA_NNP ._. The_DT
        number_NN of_IN segments_NNS for_IN each_DT patient_NN varied_VBD ,_, since_IN it_PRP was_VBD
        dependent_JJ of_IN length_NN of_IN hair_NN available_JJ from_IN each_DT individual_NN ._.
        Most_JJS patients_NNS have_VBP five_CD segments_NNS and_CC no_DT patient_NN provided_VBN
        less_JJR than_IN two_CD segments_NNS ._. The_DT concentrations_NNS used_VBN for_IN each_DT
        case_NN are_VBP the_DT mean_NN values_NNS for_IN all_DT available_JJ segments_NNS for_IN
        that_DT patient_NN ._. HPLC_NNP values_NNS are_VBP used_VBN in_IN the_DT analysis_NN of_IN CBZ_NNP
        and_CC PHT_NNP ,_, FPIA_NNP values_NNS are_VBP used_VBN in_IN the_DT analysis_NN of_IN VPA_NNP ._. As_IN
        well_RB ,_, serum_NN assay_NN values_NNS are_VBP provided_VBN for_IN each_DT patient_NN ._. The_DT
        serum_NN assay_NN typology_NN varied_VBD ,_, including_VBG multiple_JJ methods_NNS to_TO
        assay_NN serum_NN for_IN some_DT drugs_NNS ._. For_IN CBZ_NNP serum_NN was_VBD assayed_JJ by_IN
        both_DT FPIA_NNP and_CC GC_NNP /_NN MS_NNP ,_, for_IN VPA_NNP by_IN FPIA_NNP ,_, and_CC for_IN PHT_NNP by_IN FPIA_NNP
        and_CC HPLC_NNP ._. Bloods_NNP were_VBD drawn_VBN from_IN patients_NNS in_IN the_DT morning_NN by_IN
        their_PRP$ attending_VBG physician_NN ._. In_IN a_DT few_JJ cases_NNS there_EX were_VBD
        multiple_JJ bloods_NNS drawn_VBN ._. In_IN such_JJ cases_VBZ the_DT mean_NN values_NNS for_IN
        the_DT serum_NN levels_NNS are_VBP represented_VBN in_IN the_DT tables_NNS ._. Hair_NNP color_NN
        assignments_NNS were_VBD based_VBN upon_IN observation_NN by_IN the_DT attending_VBG
        physician_NN ,_, questioning_VBG of_IN the_DT patient_NN and_CC in_IN cases_NNS of_IN
        ambiguity_NN by_IN consultation_NN among_IN the_DT field_NN research_NN staff_NN ,_,
        the_DT attending_VBG physician_NN ,_, and_CC the_DT patient_NN ._.
        Since_IN this_DT is_VBZ a_DT secondary_JJ analysis_NN of_IN data_NNS ,_, only_RB a_DT
        synopsis_NNS of_IN technical_JJ procedures_NNS is_VBZ presented_VBN here_RB ._. Details_NNS
        of_IN the_DT instrumentation_NN ,_, including_VBG calibration_NN and_CC
        standardization_NN ,_, and_CC elaboration_NN of_IN the_DT analysis_NN techniques_NNS
        are_VBP described_VBN in_IN detail_NN elsewhere_RB [_NN 28_CD ]_NN and_CC are_VBP not_RB
        repeated_VBN here_RB ._. The_DT general_JJ approach_NN was_VBD as_IN follows_VBZ :_: hair_NN
        samples_NNS were_VBD dissolved_VBN in_IN a_DT strong_JJ base_NN (_( NaOH_NNP )_) and_CC the_DT
        dissolved_VBN material_NN was_VBD subjected_VBN to_TO solvent_JJ extraction_NN ._.
        Hair_NNP samples_NNS were_VBD segmented_JJ in_IN 2_CD -_: cm_NN sections_NNS ,_, and_CC 30_CD -_: 50_CD mg_NN
        of_IN hair_NN from_IN each_DT segment_NN was_VBD added_VBN to_TO 3_CD ml_NN of_IN 1_CD N_NNP NaOH_NNP
        solution_NN ._. The_DT solution_NN was_VBD solvent_JJ extracted_VBN with_IN diethyl_NN
        ether_NN ,_, centrifuged_JJ ,_, and_CC the_DT supernatant_NN evaporated_VBD ._. The_DT
        remnant_NN residue_NN was_VBD dissolved_VBN in_IN saline_NN and_CC subjected_VBN to_TO
        analysis_NN ._.
      
      
        Result_NN and_CC Discussion_NNP
        
          Carbamazepine_NNP (_( CBZ_NNP )_)
          
            General_NNP Dose_NNP /_NN Assay_NNP Relationship_NNP
            The_DT data_NNS for_IN the_DT dose_NN assay_NN relationship_NN includes_VBZ
            concentration_NN in_IN the_DT plasma_NN serum_NN ,_, which_WDT was_VBD determined_VBN
            by_IN both_DT FPIA_NNP and_CC GC_NNP ,_, and_CC concentration_NN in_IN the_DT hair_NN ,_,
            which_WDT was_VBD determined_VBN by_IN both_DT FPIA_NNP and_CC HPLC_NNP ._. For_IN hair_NN
            assays_NNS the_DT values_NNS are_VBP in_IN micrograms_NNS per_IN gram_NN of_IN hair_NN ,_,
            and_CC for_IN serum_NN the_DT values_NNS are_VBP in_IN micrograms_NNS per_IN
            milliliter_NN of_IN plasma_NN ._. The_DT findings_NNS show_VBP that_IN there_EX was_VBD
            no_DT significant_JJ dose_NN /_NN assay_NN relationship_NN for_IN the_DT serum_NN
            specimens_NNS with_IN either_DT analytic_JJ technique_NN ,_, and_CC that_IN
            there_EX was_VBD a_DT significant_JJ dose_NN /_NN assay_NN relationship_NN for_IN
            hair_NN specimens_NNS by_IN both_DT analytic_JJ techniques_NNS ._. The_DT results_NNS
            are_VBP shown_VBN in_IN Table_NNP 1_CD ._.
          
          
            Hair_NNP Color_NNP
            It_PRP has_VBZ been_VBN a_DT source_NN of_IN controversy_NN in_IN the_DT
            interpretation_NN of_IN hair_NN assays_NNS whether_IN or_CC not_RB hair_NN color_NN
            is_VBZ a_DT critical_JJ factor_NN in_IN the_DT binding_JJ of_IN materials_NNS in_IN
            hair_NN ._. It_PRP has_VBZ previously_RB reported_VBN that_IN CBZ_NNP does_VBZ not_RB
            appear_VB to_TO have_VB a_DT significant_JJ "_'' color_NN effect_NN "_'' (_( i_NNP ._. e_SYM ._. ,_, that_IN
            darker_JJR hair_NN shows_VBZ significantly_RB higher_JJR concentrations_NNS
            of_IN CBZ_NNP than_IN light_JJ hair_NN )_) [_NN 31_CD ]_NN ._. We_PRP examine_VBP this_DT finding_VBG
            using_VBG the_DT current_JJ data_NN ._. There_EX are_VBP five_CD color_NN
            categorizations_NNS of_IN hair_NN represented_VBD among_IN the_DT 40_CD
            subjects_NNS ._. The_DT distribution_NN of_IN hair_NN color_NN and_CC the_DT mean_JJ
            concentration_NN of_IN CBZ_NNP for_IN each_DT color_NN are_VBP shown_VBN in_IN Table_NNP
            2_CD ._. The_DT concentration_NN values_NNS are_VBP in_IN micrograms_NNS /_NN gram_NN as_IN
            measured_VBN by_IN HPLC_NNP ._.
            An_DT analysis_NN of_IN variance_NN for_IN this_DT table_NN fails_VBZ to_TO show_VB
            a_DT significant_JJ relationship_NN between_IN CBZ_NNP mean_VB value_NN and_CC
            hair_NN color_NN (_( F_NN =_SYM 1_CD ._. 374_CD ,_, p_NN =_SYM ._. 263_CD )_) ._. The_DT Levene_NNP Test_NNP for_IN
            equality_NN of_IN error_NN variances_NNS indicates_VBZ that_IN the_DT
            homogeneity_NN of_IN variance_NN assumption_NN is_VBZ met_VBN (_( Levene_NNP F_NNP =_SYM
            ._. 303_CD ,_, p_NN =_SYM ._. 874_CD )_) ._. The_DT K-S_NNP and_CC Shapiro-_NNP Wilk_NNP tests_NNS for_IN
            normality_NN are_VBP consistent_JJ with_IN a_DT normal_JJ distribution_NN and_CC
            a_DT normal_JJ Q-Q_NNP plot_NN of_IN CBZ_NNP concentration_NN in_IN hair_NN shows_VBZ a_DT
            good_JJ approximation_NN of_IN normality_NN ._.
          
          
            Hair_NNP Color_NNP /_NN Dose_NNP Relationship_NNP
            Another_DT factor_NN worth_JJ consideration_NN is_VBZ the_DT possible_JJ
            interaction_NN effect_NN between_IN hair_NN color_NN and_CC dose_NN ._. The_DT
            dose_NN values_NNS and_CC hair_NN color_NN categories_NNS can_MD be_VB a_DT shown_VBN as_IN
            a_DT matrix_NN array_NN as_IN in_IN Table_NNP 3_CD ._.
            Table_NNP 3_CD is_VBZ a_DT crosstabulation_NN showing_VBG the_DT distribution_NN
            of_IN dosage_NN values_NNS by_IN hair_NN color_NN ._. Review_NNP of_IN the_DT cell_NN
            distributions_NNS shows_VBZ a_DT concentration_NN of_IN higher_JJR dose_NN
            regimens_NNS to_TO cluster_NN towards_IN the_DT lower_JJR left_VBD ,_, indicating_VBG
            the_DT possibility_NN that_IN persons_NNS with_IN black_JJ hair_NN may_MD more_RBR
            likely_JJ to_TO be_VB on_IN higher_JJR doses_NNS of_IN CBZ_NNP and_CC persons_NNS with_IN
            lighter_JJR hair_NN may_MD be_VB more_RBR likely_JJ to_TO receive_VB lower_JJR doses_NNS ._.
            The_DT GLM_NNP covariance_NN model_NN is_VBZ based_VBN on_IN the_DT mean_JJ hair_NN
            assay_NN outcomes_NNS (_( HPLC_NNP )_) ._. The_DT analysis_NN of_IN covariance_NN
            (_( ANCOVA_NNP )_) allows_VBZ for_IN the_DT comparison_NN of_IN quantitative_JJ
            dependent_JJ and_CC qualitative_JJ independent_JJ variable_NN while_IN
            simultaneously_RB controlling_VBG for_IN a_DT number_NN of_IN quantitative_JJ
            variables_NNS or_CC covariates_NNS ._. In_IN this_DT analysis_NN ,_, the_DT
            dependent_JJ variable_NN is_VBZ the_DT mean_JJ concentration_NN for_IN the_DT
            hair_NN analysis_NN ,_, the_DT independent_JJ qualitative_JJ variable_NN is_VBZ
            the_DT hair_NN color_NN categorization_NN ,_, and_CC the_DT covariates_NNS are_VBP
            duration_NN of_IN dose_NN (_( in_IN months_NNS )_) ,_, dose_NN (_( in_IN mgs_NNS ._. per_IN 24_CD
            hours_NNS )_) ,_, and_CC patient_NN age_NN (_( in_IN years_NNS )_) ._. The_DT outcome_NN of_IN this_DT
            model_NN is_VBZ shown_VBN in_IN Table_NNP 4_CD ._.
            Table_NNP 4_CD reveals_VBZ that_IN there_EX is_VBZ a_DT relation_NN between_IN mean_NN
            hair_NN concentration_NN and_CC dose_NN (_( F_NN =_SYM 5_CD ._. 020_CD ,_, p_NN =_SYM ._. 032_CD ,_, eta_NN
            2_CD =_SYM ._. 136_CD ,_, shaded_JJ row_NN )_) while_IN the_DT relationship_NN between_IN
            hair_NN assay_NN result_NN and_CC color_NN is_VBZ not_RB significant_JJ (_( F_NN =_SYM
            ._. 682_CD ,_, p_NN =_SYM ._. 609_CD ,_, eta_NN 2_CD =_SYM ._. 079_CD )_) ._. Thus_RB it_PRP is_VBZ reasonable_JJ to_TO
            conclude_VB that_DT differential_NN hair_NN assay_NN outcomes_NNS for_IN CBZ_NNP
            are_VBP not_RB color_VB dependent_JJ ,_, but_CC are_VBP significantly_RB related_VBN
            to_TO dose_NN regimens_NNS ._.
          
        
        
          Valproic_NNP Acid_NNP (_( VPA_NNP )_)
          
            General_NNP Dose_NNP /_NN Assay_NNP Relationship_NNP
            The_DT data_NNS for_IN the_DT VPA_NNP dose_NN assay_NN relationship_NN
            includes_VBZ concentration_NN in_IN the_DT plasma_NN serum_NN ,_, which_WDT was_VBD
            determined_VBN by_IN FPIA_NNP ,_, and_CC concentration_NN in_IN the_DT hair_NN ,_,
            which_WDT was_VBD determined_VBN by_IN FPIA_NNP ._. For_IN hair_NN assays_NNS the_DT
            values_NNS are_VBP in_IN micrograms_NNS per_IN gram_NN of_IN hair_NN ,_, and_CC for_IN
            serum_NN the_DT values_NNS are_VBP in_IN micrograms_NNS per_IN milliliter_NN of_IN
            plasma_NN ._. The_DT findings_NNS show_VBP that_IN there_EX was_VBD no_DT significant_JJ
            dose_NN /_NN assay_NN relationship_NN for_IN the_DT VPA_NNP serum_NN specimens_NNS ,_,
            and_CC that_IN there_EX was_VBD a_DT significant_JJ correlation_NN dose_NN /_NN assay_NN
            relationship_NN for_IN VPA_NNP hair_NN specimens_NNS ._. The_DT results_NNS are_VBP
            shown_VBN in_IN Table_NNP 5_CD ._.
          
          
            Hair_NNP Color_NNP
            As_IN with_IN CBZ_NNP ,_, we_PRP will_MD examine_VB the_DT potential_NN for_IN a_DT
            "_'' color_NN effect_NN "_'' associated_VBN with_IN the_DT reported_VBN
            concentrations_NNS of_IN recovered_VBD VPA_NNP ._. The_DT color_NN
            categorizations_NNS are_VBP identical_JJ to_TO those_DT used_VBN for_IN CBZ_NNP ._.
            Table_NNP 6_CD reports_NNS the_DT mean_JJ concentration_NN of_IN VPA_NNP by_IN hair_NN
            color_NN category_NN ._. There_EX are_VBP no_DT dyed_VBN specimens_NNS so_RB four_CD
            color_NN categories_NNS are_VBP used_VBN in_IN this_DT analysis_NN ._.
            An_DT analysis_NN of_IN variance_NN for_IN Table_NNP 6_CD fails_VBZ to_TO show_VB a_DT
            significant_JJ relationship_NN between_IN VPA_NNP mean_VB values_NNS and_CC
            hair_NN color_NN (_( F_NN =_SYM 2_CD ._. 354_CD ,_, p_NN =_SYM ._. 088_CD )_) ._. The_DT Levene_NNP Test_NNP for_IN
            equality_NN of_IN error_NN variances_NNS indicates_VBZ that_IN the_DT
            homogeneity_NN of_IN variances_NNS assumptions_NNS is_VBZ met_VBN (_( Levene_NNP F_NNP =_SYM
            2_CD ._. 491_CD ,_, p_NN =_SYM ._. 076_CD )_) ._. The_DT K-S_NNP test_NN for_IN normality_NN is_VBZ
            consistent_JJ with_IN a_DT normal_JJ distribution_NN and_CC a_DT normal_JJ Q-Q_NNP
            plot_NN of_IN VPA_NNP concentration_NN in_IN hair_NN shows_VBZ a_DT good_JJ
            approximation_NN of_IN normality_NN ._.
          
          
            Hair_NNP Color_NNP Relationship_NNP
            As_IN with_IN CBZ_NNP ,_, we_PRP now_RB consider_VBP the_DT possible_JJ
            interaction_NN of_IN hair_NN color_NN ,_, dose_NN ,_, and_CC recovered_VBD VPA_NNP from_IN
            hair_NN ._. Table_NNP 7_CD presents_VBZ the_DT frequency_NN distribution_NN of_IN
            dose_NN by_IN hair_NN color_NN ._.
            Visual_NNP inspection_NN of_IN the_DT Table_NNP 7_CD is_VBZ consistent_JJ with_IN
            the_DT impression_NN that_IN there_EX may_MD be_VB a_DT slight_JJ skewing_VBG of_IN
            higher_JJR dosage_NN regimens_NNS towards_IN dark-haired_JJ subjects_NNS ._. We_PRP
            subject_VB this_DT data_NNS to_TO an_DT ANCOVA_NNP ._. As_IN previously_RB ,_, we_PRP treat_VBP
            mean_VB concentration_NN as_IN the_DT dependent_JJ term_NN ,_, color_NN as_IN the_DT
            independent_JJ qualitative_JJ term_NN ,_, and_CC dose_NN duration_NN ,_,
            24_CD -_: hour_NN dose_NN value_NN and_CC age_NN as_IN the_DT covariates_NNS ._. The_DT
            outcome_NN for_IN this_DT model_NN is_VBZ reported_VBN in_IN Table_NNP 8_CD ._. The_DT
            Levene_NNP statistic_NN shows_VBZ the_DT variance_NN homogeneity_NN
            criteria_NNS are_VBP met_VBN ,_, and_CC analysis_NN of_IN the_DT normality_NN of_IN the_DT
            distribution_NN of_IN the_DT mean_JJ hair_NN values_NNS shows_VBZ acceptable_JJ
            conformity_NN with_IN normality_NN assumptions_NNS ._.
            Table_NNP 8_CD demonstrates_VBZ that_IN the_DT relationships_NNS between_IN
            dose_NN ,_, age_NN ,_, and_CC hair_NN color_NN are_VBP all_DT significant_JJ (_( shaded_JJ
            rows_NNS )_) ,_, while_IN duration_NN of_IN dose_NN regimen_NN is_VBZ not_RB ._.
            Furthermore_RB the_DT eta_NN 2_CD values_NNS ,_, which_WDT are_VBP interpretable_JJ as_IN
            a_DT measure_NN of_IN the_DT percentage_NN of_IN the_DT explainable_JJ
            variance_NN ,_, show_NN similar_JJ contributions_NNS between_IN color_NN and_CC
            dose_NN ,_, and_CC a_DT lesser_JJR contribution_NN due_JJ to_TO age_NN ._. Table_NNP
            9_CD reports_NNS these_DT contrasts_VBZ using_VBG Bonferroni_NNP 's_POS
            criteria_NNS ._.
            The_DT Bonferroni_NNP criteria_NNS contrasts_VBZ indicate_VBP that_IN
            specific_JJ pair_NN comparisons_NNS do_VBP not_RB yield_VB a_DT significant_JJ
            difference_NN ,_, although_IN the_DT contrasts_VBZ for_IN black_JJ /_NN gray_JJ and_CC
            black_JJ /_NN blond_JJ are_VBP approaching_VBG significance_NN ._. Doing_VBG the_DT
            pairs_NNS comparisons_NNS using_VBG Sidak_NNP criteria_NNS yields_VBZ the_DT same_JJ
            results_NNS ._. Both_DT of_IN these_DT confidence_NN interval_NN criteria_NNS are_VBP
            conservative_JJ but_CC the_DT Bonferroni_NNP criteria_NNS are_VBP preferred_VBN
            on_IN the_DT basis_NN that_IN there_EX is_VBZ a_DT relatively_RB small_JJ number_NN of_IN
            comparison_NN pairs_NNS ._.
            An_DT additional_JJ issue_NN of_IN importance_NN is_VBZ the_DT potential_JJ
            complex_JJ interaction_NN between_IN dose_NN ,_, age_NN ,_, and_CC color_NN
            categorization_NN ._. First_LS ,_, the_DT data_NNS demonstrate_VBP a_DT
            difference_NN in_IN mean_NN dose_NN value_NN by_IN age_NN ,_, although_IN those_DT
            differences_NNS are_VBP not_RB significant_JJ for_IN VPA_NNP (_( the_DT
            correlation_NN for_IN dose_NN and_CC age_NN is_VBZ r_LS =_SYM ._. 265_CD ,_, p_NN =_SYM ._. 098_CD )_) ._.
            Furthermore_RB ,_, the_DT covariance_NN model_NN can_MD be_VB used_VBN to_TO
            generate_VB model_NN regression-derived_JJ mean_NN estimates_NNS
            (_( adjusted_VBN for_IN age_NN and_CC dose_NN )_) that_WDT can_MD be_VB compared_VBN to_TO the_DT
            observed_VBD values_NNS ._. Both_DT the_DT analytic_JJ values_NNS and_CC the_DT
            estimated_VBN values_NNS are_VBP shown_VBN in_IN Table_NNP 10_CD ._.
            Comparison_NNP of_IN the_DT observed_VBN mean_NN values_NNS and_CC the_DT
            model-estimated_JJ mean_NN values_NNS shows_VBZ that_IN the_DT model_NN is_VBZ
            relatively_RB efficient_JJ for_IN all_DT color_NN categorizations_NNS
            except_IN gray_JJ hair_NN ,_, where_WRB the_DT observed_VBD values_NNS are_VBP nearly_RB
            twice_RB the_DT value_NN of_IN the_DT estimated_VBN values_NNS ._. Since_IN age_NN and_CC
            gray_JJ hair_NN are_VBP collinear_NN in_IN the_DT data_NNS set_VBD Table_NNP 10_CD ,_, it_PRP is_VBZ
            possible_JJ that_IN the_DT age_NN /_NN color_NN account_NN for_IN this_DT departure_NN ._.
            Regression_NNP evaluation_NN of_IN the_DT color_NN /_NN age_NN collinearity_NN for_IN
            either_DT dose_NN or_CC mean_VB concentration_NN is_VBZ consistent_JJ with_IN
            this_DT effect_NN (_( eigenvalue_NN ,_, age_NN =_SYM ._. 228_CD ,_, eigenvalue_NN ,_, color_NN
            =_SYM ._. 081_CD )_) ._. Small_JJ eigenvalues_NNS are_VBP consistent_JJ with_IN
            collinearity_NN between_IN the_DT covariate_NN factors_NNS ,_, and_CC thus_RB
            these_DT values_NNS are_VBP indicative_JJ of_IN an_DT age_NN /_NN color_NN collinear_NN
            condition_NN ._.
            To_TO further_VB examine_VB this_DT effect_NN ,_, we_PRP produce_VBP a_DT final_JJ
            covariance_NN model_NN for_IN VPA_NNP with_IN color_NN categorization_NN as_IN
            the_DT independent_JJ factor_NN and_CC dose_NN as_IN the_DT covariate_NN ._. The_DT
            results_NNS of_IN this_DT model_NN are_VBP presented_VBN in_IN Table_NNP 11_CD ._.
            The_DT 2_CD -_: factor_NN model_NN (_( dose_NN and_CC color_NN )_) presented_VBN in_IN
            Table_NNP 11_CD are_VBP consistent_JJ with_IN the_DT conjecture_NN that_DT age_NN and_CC
            color_NN demonstrate_VBP some_DT interactive_JJ or_CC synergistic_JJ
            effect_NN ,_, since_IN color_NN alone_RB fails_VBZ to_TO attain_VB
            significance_NN ._.
            It_PRP is_VBZ reasonable_JJ to_TO surmise_NN that_IN the_DT color_NN effect_NN
            for_IN VPA_NNP is_VBZ ,_, at_IN best_JJS ,_, weak_JJ and_CC mostly_RB likely_JJ collinear_NN
            with_IN age_NN ._. However_RB ,_, there_EX is_VBZ an_DT effect_NN for_IN color_NN that_WDT is_VBZ
            operating_VBG as_IN a_DT stronger_JJR effect_NN than_IN discerned_JJ in_IN the_DT
            analysis_NN of_IN CBZ_NNP ._. This_DT effect_NN appears_VBZ to_TO be_VB dependent_JJ on_IN
            the_DT stringency_NN of_IN the_DT significance_NN criteria_NNS used_VBN in_IN the_DT
            analysis_NN ,_, and_CC the_DT degree_NN to_TO which_WDT the_DT analytic_JJ model_NN
            disaggregates_NNS the_DT hypothesized_VBN variable_JJ relationships_NNS ._.
            Selecting_NNP less_RBR conservative_JJ criteria_NNS will_MD produce_VB a_DT
            weak_JJ ,_, generalized_JJ significant_JJ color_NN /_NN assay_NN relationship_NN ,_,
            but_CC application_NN of_IN either_DT more_RBR conservative_JJ methods_NNS to_TO
            assess_VB pair-relationships_JJ (_( e_SYM ._. g_SYM ._. Bonferroni_NNP criteria_NNS )_) ,_,
            or_CC use_NN of_IN more_JJR elaborate_VB model_NN specifications_NNS (_( e_SYM ._. g_SYM ._. ,_,
            step-wise_JJ ANCOVA_NNP )_) fail_VB to_TO sustain_VB significance_NN ._. One_CD of_IN
            the_DT more_RBR serious_JJ constraints_NNS on_IN the_DT VPA_NNP analysis_NN
            presented_VBN here_RB is_VBZ the_DT very_RB limited_JJ number_NN of_IN persons_NNS
            with_IN gray_JJ hair_NN ,_, and_CC the_DT number_NN of_IN light-haired_JJ persons_NNS
            in_IN general_JJ (_( only_RB 6_CD of_IN the_DT 40_CD subjects_NNS were_VBD not_RB
            classified_VBN as_IN either_DT black_JJ or_CC brown_JJ hair_NN )_) ._. A_DT more_RBR
            confident_JJ analysis_NN would_MD require_VB a_DT sample_NN with_IN larger_JJR
            numbers_NNS
          
        
        
          Phenytoin_NNP (_( PHT_NNP )_)
          
            General_NNP Dose_NNP /_NN Assay_NNP Relationship_NNP
            The_DT data_NNS for_IN the_DT dose_NN assay_NN relationship_NN includes_VBZ
            concentration_NN in_IN the_DT plasma_NN serum_NN ,_, which_WDT was_VBD determined_VBN
            by_IN HPLC_NNP ,_, and_CC concentration_NN in_IN the_DT hair_NN ,_, which_WDT was_VBD
            determined_VBN by_IN both_DT FPIA_NNP and_CC HPLC_NNP ._. For_IN hair_NN assays_NNS the_DT
            values_NNS are_VBP in_IN micrograms_NNS per_IN gram_NN of_IN hair_NN ,_, and_CC for_IN
            serum_NN the_DT values_NNS are_VBP in_IN micrograms_NNS per_IN milliliter_NN of_IN
            plasma_NN ._.
            We_PRP note_VBP that_IN ,_, in_IN contrast_NN to_TO both_DT CBZ_NNP and_CC VPA_NNP ,_, Table_NNP
            12_CD reveals_VBZ that_IN there_EX is_VBZ a_DT significant_JJ bivariate_NN
            dose_NN /_NN assay_NN correlation_NN for_IN the_DT serum_NN specimens_NNS ,_, and_CC for_IN
            the_DT hair_NN specimens_NNS by_IN both_DT analytic_JJ techniques_NNS ._.
          
          
            Hair_NNP Color_NNP
            Table_NNP 13_CD reports_NNS the_DT number_NN of_IN subjects_NNS for_IN each_DT of_IN
            four_CD hair_NN color_NN categorizations_NNS ,_, the_DT mean_JJ concentration_NN
            of_IN PHT_NNP for_IN that_DT color_NN category_NN ,_, and_CC the_DT related_VBN
            standard_JJ deviation_NN ._. Visual_NNP examination_NN of_IN the_DT table_NN
            shows_VBZ that_IN both_DT black_JJ and_CC brown_JJ color_NN had_VBD notably_RB
            higher_JJR concentrations_NNS than_IN either_DT blond-haired_JJ or_CC
            gray-haired_JJ subjects_NNS ._.
            A_DT univariate_NN ANOVA_NNP on_IN the_DT data_NNS in_IN Table_NNP 13_CD reveal_VB
            that_IN there_EX is_VBZ a_DT significant_JJ difference_NN by_IN hair_NN color_NN (_( F_NN
            =_SYM 10_CD ._. 2_LS ,_, p_NN =_SYM ._. 000_CD )_) ._. However_RB ,_, the_DT Levene_NNP Test_NNP indicates_VBZ
            that_IN the_DT homogeneity_NN of_IN variance_NN assumption_NN is_VBZ not_RB met_VBN ._.
            An_DT alternative_JJ analysis_NN using_VBG Tamhane_NNP 's_POS procedure_NN ,_,
            allowing_VBG an_DT assessment_NN of_IN unequal_JJ variances_NNS
            comparisons_NNS ,_, also_RB indicates_VBZ significance_NN ,_, but_CC allows_VBZ
            for_IN post-hoc_JJ contrasts_VBZ for_IN each_DT specific_JJ color_NN group_NN ._.
            The_DT individual_JJ comparisons_NNS are_VBP shown_VBN in_IN Table_NNP 14_CD ._.
            The_DT ANOVA_NNP indicates_VBZ that_IN that_DT there_EX are_VBP significant_JJ
            differences_NNS in_IN concentration_NN of_IN PHT_NNP by_IN hair_NN color_NN ._. The_DT
            overall_JJ mean_NN concentration_NN values_NNS appear_VBP to_TO cluster_NN ,_,
            with_IN the_DT black_JJ /_NN brown_JJ hair_NN contrast_NN showing_VBG no_DT
            significant_JJ difference_NN ,_, and_CC blond_JJ /_NN gray_JJ contrast_NN showing_VBG
            no_DT significant_JJ difference_NN ._. However_RB ,_, contrast_NN of_IN either_DT
            blond_JJ or_CC gray_JJ hair_NN to_TO black_JJ or_CC brown_JJ hair_NN does_VBZ show_NN
            significant_JJ difference_NN ._. The_DT overall_JJ distribution_NN of_IN PHT_NNP
            in_IN the_DT hair_NN assays_NNS appears_VBZ to_TO meet_VB the_DT normality_NN
            assumptions_NNS well_RB ._.
          
          
            Hair_NNP Color_NNP /_NN Dose_NNP Relationship_NNP
            In_IN order_NN to_TO further_VB assess_VB the_DT nature_NN of_IN the_DT
            hypothesized_VBN color_NN effect_NN ,_, it_PRP is_VBZ important_JJ to_TO assess_VB
            whether_IN or_CC not_RB there_EX is_VBZ an_DT interaction_NN effect_NN of_IN color_NN
            and_CC dose_NN ._. Is_VBZ the_DT effect_NN a_DT result_NN of_IN dosing_VBG values_NNS are_VBP
            higher_JJR for_IN dark-haired_JJ subjects_NNS ?_. Table_NNP 15_CD reports_NNS the_DT
            relative_JJ frequency_NN of_IN daily_JJ dose_NN regimens_NNS by_IN hair_NN color_NN
            group_NN ._.
            Table_NNP 15_CD indicates_VBZ that_IN the_DT higher_JJR dose_NN values_NNS appear_VBP
            to_TO cluster_NN to_TO some_DT degree_NN with_IN black_JJ and_CC brown-haired_JJ
            subjects_NNS ._. In_IN order_NN to_TO assess_VB this_DT an_DT ANCOVA_NNP model_NN
            including_VBG dose_NN ,_, dose_NN duration_NN ,_, age_NN ,_, and_CC hair_NN color_NN is_VBZ
            assessed_VBN ._. Results_NNS of_IN that_DT model_NN are_VBP shown_VBN in_IN Table_NNP
            16_CD ._.
            Table_NNP 16_CD indicates_VBZ that_DT age_NN ,_, dose_NN ,_, and_CC color_NN are_VBP
            significant_JJ factors_NNS in_IN the_DT model_NN (_( values_NNS shaded_JJ gray_JJ
            are_VBP significant_JJ )_) while_IN dose_NN duration_NN is_VBZ not_RB ._. This_DT is_VBZ
            identical_JJ to_TO the_DT model_NN outcome_NN for_IN VPA_NNP ._. Table_NNP 17_CD shows_VBZ
            the_DT Bonferroni_NNP criteria_NNS for_IN all_DT pairwise_NN combinations_NNS ,_,
            their_PRP$ means_NNS differences_NNS ,_, and_CC their_PRP$ significance_NN
            outcomes_NNS ._.
            As_IN with_IN VPA_NNP ,_, the_DT pairwise_NN contrasts_VBZ show_NN that_IN the_DT
            black_JJ and_CC gray_JJ and_CC brown_JJ and_CC gray_JJ contrasts_VBZ are_VBP
            significant_JJ ,_, while_IN the_DT remaining_VBG pairs_NNS do_VBP not_RB have_VB
            significant_JJ mean_NN differences_NNS (_( the_DT same_JJ results_NNS is_VBZ
            obtained_VBN using_VBG Sidak_NNP criteria_NNS )_) ._. It_PRP suggests_VBZ ,_, as_IN with_IN
            VPA_NNP ,_, that_IN there_EX may_MD be_VB a_DT color_NN /_NN age_NN /_NN dose_NN confounding_VBG
            action_NN involving_VBG either_CC collinear_NN or_CC confounding_VBG
            relationships_NNS between_IN hair_NN color_NN ,_, dose_NN ,_, and_CC age_NN ._. In_IN
            order_NN to_TO assess_VB this_DT we_PRP first_JJ consider_VB the_DT observed_VBD
            means_VBZ and_CC the_DT estimates_NNS mean_VBP values_NNS from_IN the_DT ANCOVA_NNP
            model_NN ._. This_DT is_VBZ presented_VBN in_IN Table_NNP 18_CD ._.
            Table_NNP 18_CD reveals_VBZ that_IN the_DT model-estimated_JJ means_NNS for_IN
            dark_JJ hair_NN (_( black_JJ and_CC brown_JJ )_) are_VBP lower_JJR than_IN the_DT observed_VBN
            values_NNS ,_, and_CC the_DT estimates_NNS for_IN light_JJ colored_VBN hair_NN are_VBP
            greater_JJR ._. This_DT is_VBZ a_DT departure_NN from_IN the_DT VPA_NNP pattern_NN ,_, and_CC
            is_VBZ consistent_JJ across_IN category_NN with_IN a_DT
            color_NN /_NN concentration_NN positive_JJ relationship_NN ._.
            We_PRP can_MD assess_VB this_DT effect_NN by_IN examining_VBG the_DT ANCOVA_NNP
            model_NN retaining_VBG dose_NN and_CC hair_NN color_NN as_IN the_DT sole_JJ
            covariates_NNS (_( replicating_VBG the_DT procedure_NN applied_VBN to_TO VPA_NNP )_)
            and_CC examining_VBG the_DT surviving_VBG significant_JJ relationship_NN ._.
            The_DT results_NNS of_IN this_DT model_NN are_VBP shown_VBN in_IN Table_NNP 19_CD ._.
            Consistent_NNP with_IN the_DT approach_NN applied_VBN to_TO VPA_NNP ,_, we_PRP
            delete_VB age_NN from_IN the_DT model_NN in_IN Table_NNP 19_CD ._. Age_NNP is_VBZ removed_VBN
            from_IN the_DT model_NN in_IN this_DT case_NN to_TO see_VB if_IN it_PRP diminishes_VBZ the_DT
            color_NN effect_NN ,_, as_IN was_VBD the_DT case_NN VPA_NNP ._. Comparison_NNP of_IN Tables_NNP
            17_CD and_CC 18_CD show_NN that_IN the_DT eta_NN 2_CD is_VBZ diminished_VBN ,_, but_CC is_VBZ still_RB
            significant_JJ and_CC makes_VBZ a_DT substantial_JJ contribution_NN to_TO the_DT
            explained_VBN variance_NN ._. Dose_NNP still_RB has_VBZ ,_, however_RB ,_, the_DT higher_JJR
            eta_NN 2_CD value_NN ._. Further_RB pairwise_NN comparisons_NNS show_VBP that_IN
            there_EX are_VBP significant_JJ mean_NN value_NN contrasts_VBZ between_IN the_DT
            light_JJ hair_NN categories_NNS (_( gray_JJ and_CC blond_JJ )_) and_CC the_DT dark_JJ
            hair_NN categories_NNS (_( black_JJ and_CC brown_JJ )_) ._. There_EX are_VBP ,_, however_RB ,_,
            no_DT significant_JJ contrasts_VBZ within_IN those_DT groups_NNS (_( i_NNP ._. e_SYM ._. ,_, no_DT
            significant_JJ mean_NN differences_NNS between_IN black_JJ and_CC brown_JJ
            hair_NN or_CC blond_JJ and_CC gray_JJ hair_NN )_) ._.
          
        
      
      
        Conclusions_NNP
        This_DT assessment_NN of_IN the_DT recovery_NN of_IN three_CD compounds_NNS ,_, CBZ_NNP ,_,
        VPA_NNP ,_, and_CC PHT_NNP ,_, from_IN hair_NN samples_NNS identifies_VBZ a_DT variable_JJ
        effect_NN of_IN hair_NN color_NN on_IN assay_NN concentration_NN by_IN drug_NN type_NN ._.
        The_DT generalized_JJ hypothesis_NNS assessed_VBN is_VBZ that_IN darker_JJR
        coloration_NN of_IN hair_NN is_VBZ associated_VBN with_IN a_DT greater_JJR
        concentration_NN of_IN analyte_NN in_IN the_DT hair_NN ._. For_IN CBZ_NNP ,_, hair_NN color_NN
        does_VBZ not_RB appear_VB to_TO exert_VB a_DT significant_JJ effect_NN on_IN the_DT
        quantity_NN of_IN the_DT compound_NN recovered_VBD from_IN hair_NN ._. For_IN VPA_NNP there_EX
        appears_VBZ to_TO be_VB a_DT very_RB weak_JJ color_NN effect_NN ,_, but_CC the_DT number_NN of_IN
        light-haired_JJ subjects_NNS attenuates_NNS the_DT strength_NN of_IN the_DT
        conclusion_NN ._. For_IN all_DT drugs_NNS there_RB appears_VBZ to_TO be_VB a_DT significant_JJ
        positive_JJ relationship_NN between_IN dose_NN and_CC hair_NN concentration_NN ._.
        We_PRP also_RB suggest_VBP that_IN for_IN VPA_NNP there_EX appears_VBZ to_TO be_VB effects_NNS of_IN
        collinearity_NN between_IN age_NN and_CC hair_NN color_NN ,_, and_CC possibly_RB dose_NN
        and_CC hair_NN color_NN ._. Both_DT of_IN these_DT phenomena_NNS could_MD produce_VB
        confounding_VBG effects_NNS in_IN trying_VBG to_TO describe_VB the_DT dose_NN /_NN assay_NN
        relationship_NN ._. The_DT limitations_NNS of_IN the_DT data_NNS are_VBP that_IN the_DT
        subjects_NNS are_VBP a_DT clinical_JJ ,_, non-random_JJ ,_, population_NN and_CC the_DT
        range_NN of_IN dosages_NNS across_IN all_DT color_NN grouping_VBG was_VBD not_RB uniform_NN ,_,
        nor_CC was_VBD dosage_NN duration_NN ._. Furthermore_RB ,_, the_DT number_NN of_IN light_JJ
        hair_NN subjects_NNS was_VBD ,_, for_IN certain_JJ drugs_NNS ,_, very_RB small_JJ ._.
        Hair_NNP Color_NNP ,_, Dose_NNP ,_, Dose_NNP Duration_NNP ,_, HPLC_NNP and_CC FPIA_NNP
        Concentration_NNP per_IN Segment_NNP ,_, HPLC_NNP and_CC FPIA_NNP Serum_NNP
        Concentration_NNP ,_, Carbamazepine_NNP
        
        Raw_NNP patient_NN data_NNS for_IN carbamazepine_NN analysis_NN of_IN hair_NN and_CC
        serum_NN ._.
        CBZ_NNP Data_NNP Table_NNP ._. doc_NN
        Hair_NNP Color_NNP ,_, Dose_NNP ,_, Dose_NNP Duration_NNP ,_, HPLC_NNP and_CC FPIA_NNP
        Concentration_NNP per_IN Segment_NNP ,_, HPLC_NNP and_CC FPIA_NNP Serum_NNP
        Concentration_NNP ,_, Valproic_NNP Acid_NNP
        
        Raw_NNP patient_NN data_NNS for_IN valproic_JJ acid_NN analysis_NN of_IN hair_NN and_CC
        serum_NN ._.
        VPA_NNP Data_NNP Table_NNP ._. doc_NN
        Hair_NNP Color_NNP ,_, Dose_NNP ,_, Dose_NNP Duration_NNP ,_, HPLC_NNP and_CC FPIA_NNP
        Concentration_NNP per_IN Segment_NNP ,_, HPLC_NNP and_CC FPIA_NNP Serum_NNP
        Concentration_NNP ,_, Phenytoin_NNP
        
        Raw_NNP patient_NN data_NNS for_IN phenytoin_NN analysis_NN of_IN hair_NN and_CC
        serum_NN ._.
        PHT_NNP Data_NNP Table_NNP ._. doc_NN
      
    
  
